Evidence map›Paper›PMID 22102821›Full record

ArticlePLoS genetics2011

Relative burden of large CNVs on a range of neurodevelopmental phenotypes.

Santhosh Girirajan, Zoran Brkanac, Bradley P Coe, Carl Baker, Laura Vives, Tiffany H Vu, Neil Shafer, Raphael Bernier, Giovanni B Ferrero, Margherita Silengo and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 4 pooled it
20.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 4 syntheses or guidelines pooled it, 335 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Effects of gene dosage and development on subcortical nuclei volumes in individuals with 22q11.2 copy number variations.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  19. Article
  20. Longitudinal Development of Thalamocortical Functional Connectivity in 22q11.2 Deletion Syndrome.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024
    Article

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Santhosh GirirajanDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, Washington, United States of America.
Zoran Brkanac
Bradley P Coe
Carl Baker
Laura Vives
Tiffany H Vu
Neil Shafer
Raphael Bernier
Giovanni B Ferrero
Margherita Silengo
Stephen T Warren
Carlos S Moreno
Marco Fichera
Corrado Romano
Wendy H Raskind
Evan E Eichler
University of Washington · USEmory University · USOasi Maria SS · ITUniversity of Turin · ITUniversity of Washington Medical Center · US

Funding

Genomic Identification of Autism LociR01HD065285 · NICHD · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2009 to 2010
$2.6M
Genetics Contributions to Endophenotypes of DyslexiaR01HD054562 · NICHD · UNIVERSITY OF WASHINGTON · PI RASKIND, WENDY H · 2007 to 2011
$1.8M
Howard Hughes Medical InstituteNICHD NIH HHS 1R01 HD065285NICHD NIH HHS 5R01 HD054562NICHD NIH HHS R01 HD054562NICHD NIH HHS R01 HD065285Wellcome Trust
6 · The paper itself

Abstract

While numerous studies have implicated copy number variants (CNVs) in a range of neurological phenotypes, the impact relative to disease severity has been difficult to ascertain due to small sample sizes, lack of phenotypic details, and heterogeneity in platforms used for discovery. Using a customized microarray enriched for genomic hotspots, we assayed for large CNVs among 1,227 individuals with various neurological deficits including dyslexia (376), sporadic autism (350), and intellectual disability (ID) (501), as well as 337 controls. We show that the frequency of large CNVs (>1 Mbp) is significantly greater for ID-associated phenotypes compared to autism (p = 9.58 × 10(-11), odds ratio = 4.59), dyslexia (p = 3.81 × 10(-18), odds ratio = 14.45), or controls (p = 2.75 × 10(-17), odds ratio = 13.71). There is a striking difference in the frequency of rare CNVs (>50 kbp) in autism (10%, p = 2.4 × 10(-6), odds ratio = 6) or ID (16%, p = 3.55 × 10(-12), odds ratio = 10) compared to dyslexia (2%) with essentially no difference in large CNV burden among dyslexia patients compared to controls. Rare CNVs were more likely to arise de novo (64%) in ID when compared to autism (40%) or dyslexia (0%). We observed a significantly increased large CNV burden in individuals with ID and multiple congenital anomalies (MCA) compared to ID alone (p = 0.001, odds ratio = 2.54). Our data suggest that large CNV burden positively correlates with the severity of childhood disability: ID with MCA being most severely affected and dyslexics being indistinguishable from controls. When autism without ID was considered separately, the increase in CNV burden was modest compared to controls (p = 0.07, odds ratio = 2.33).

Indexed as

AdolescentAutistic DisorderChildComparative Genomic HybridizationCytoskeletal ProteinsDNA Copy Number VariationsDyslexiaEndopeptidasesFemaleForkhead Transcription FactorsGenetic Association StudiesGenetic Predisposition to DiseaseHumansIntellectual DisabilityMaleNervous System MalformationsAUTS2 protein, humanCytoskeletal ProteinsEndopeptidasesForkhead Transcription FactorsFOXP1 protein, humanIMMP2L protein, humanProteinsRepressor ProteinsTranscription Factors

Identifiers

PMID22102821
PMCPMC3213131
OpenAlexW2145709699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.